A role for ceftazidime/avibactam combination therapy: the question may still be on the table
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s15010-024-02331-9.pdf
Reference5 articles.
1. Hsu W, Chuang MH, Tsai WW, Lai CC, Lai HY, Tang HJ. Ceftazidime-Avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection: a systemic review and meta-analysis. Infect Published Online May. 2024;13. https://doi.org/10.1007/s15010-024-02277-y.
2. Tumbarello M, Raffaelli F, Giannella M, et al. Ceftazidime-Avibactam Use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a Retrospective Observational Multicenter Study. Clin Infect Dis. 2021;73(9):1664–76. https://doi.org/10.1093/cid/ciab176.
3. Paul M, Carrara E, Retamar P, et al. European Society of Clinical Microbiology and Infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521–47. https://doi.org/10.1016/j.cmi.2021.11.025.
4. Oliva A, Volpicelli L, Di Bari S, et al. Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: results from a multicentre retrospective study. JAC Antimicrob Resist. 2022;4(6):dlac121. https://doi.org/10.1093/jacamr/dlac121. Published 2022 Dec 7.
5. Shields RK, Nguyen MH, Chen L, Press EG, Kreiswirth BN, Clancy CJ. Pneumonia and renal replacement therapy are risk factors for Ceftazidime-Avibactam treatment failures and resistance among patients with Carbapenem-Resistant Enterobacteriaceae infections. Antimicrob Agents Chemother. 2018;62(5):e02497–17. https://doi.org/10.1128/AAC.02497-17. Published 2018 Apr 26.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3